CD8A and neoplasm: In order to demonstrate that tumor rejection in mice depleted for CD8+ T cells and Tregs (Fig. 4e) was due to effector CD4+ T-cell responses, tumor growth was tested in mice lacking both CD4+ (including Tregs) and CD8+ T cells.